Bardet-Biedl综合征儿童内分泌特征:大型单中心儿科多学科门诊分析
该研究回顾性分析135例基因确诊的BBS儿科患者,描述内分泌疾病患病率及生长结局。15岁及以上患者中21.1%身材矮小、77.6%肥胖,甘油三酯升高占55.5%;性腺功能减退、甲状腺功能减退及胰岛素抵抗患病率低于成人BBS人群。
要点
- 儿童BBS以身材矮小和肥胖为特征,BMI随年龄增长恶化。
- 持续性原发或继发性性腺功能减退未见,无需青春期诱导或性激素替代。
- 原发甲减1.7%、亚临床甲减0.8%,1型糖尿病1.5%、2型糖尿病2.2%、糖耐量受损1.5%。
核心结论
- 儿童BBS以身材矮小和肥胖为特征,但性腺功能减退、甲状腺功能减退及胰岛素抵抗患病率低于成人BBS人群。
研究设计与样本
- 单中心多学科BBS门诊基因确诊儿科患者的回顾性分析,数据为前瞻性收集,共纳入135例,年龄1.2至19.4岁,女性69例(51%)。
主要发现
- 15岁及以上患者中21.1%(12/57)身材矮小,77.6%(45/58)肥胖,BMI平均随时间恶化。
- 甘油三酯升高占55.5%(66/119)。
- 无患者有持续性原发或继发性性腺功能减退的生化或临床证据,无人需青春期诱导或性激素替代治疗。
- 原发甲减占1.7%(2/121),亚临床甲减占0.8%(1/121)。
- 1型糖尿病占1.5%(2/135),2型糖尿病占2.2%(3/135),糖耐量受损占1.5%(2/135)。
关键数值与推荐
- 身材矮小定义为身高z评分(SDS)小于-2或身高低于中亲身高1.6 SDS以上。
- 身高报告适用于4岁及以上和15岁及以上患者。
临床怎么用
- 儿童BBS随访应关注肥胖及BMI恶化趋势,并监测甘油三酯。
- 儿童BBS中性腺功能减退和甲状腺功能减退患病率较低,但仍需按临床情况评估。
局限性
- 单中心回顾性分析,数据来自单一多学科服务。
- 需跨越儿科与成人人群的纵向研究进一步刻画BBS相关内分泌疾病的自然史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Bardet-Biedl syndrome (BBS) is a rare genetic ciliopathy characterized by obesity, rod-cone dystrophy, polydactyly, hypogonadism, cognitive impairment, and renal abnormalities. Additional endocrine associations include short stature and hypothyroidism. The endocrine characteristics in children are not well described. OBJECTIVE: The aim of this study was to describe the prevalence of endocrine disorders and to characterize auxology outcomes in children and young people with BSS from a large pediatric cohort at a single-center multidisciplinary service. METHODS: A retrospective analysis of prospectively collected data in pediatric patients with genetically confirmed BBS from a single multidisciplinary BBS service. Data related to endocrine function were extracted from the electronic patient record. Height was reported for patients age 4 years or older and 15 years or older. Short stature was defined as a height z score (SD score, SDS) less than -2 or height greater than 1.6 SDS below the midparental height. RESULTS: A total of 135 patients were included: 69 (51%) were female, ranging from age 1.2 to 19.4 years. At age 15 years or older, 21.1% (12/57) had short stature and 77.6% (45/58) had obesity. On average, body mass index worsened over time. Triglycerides were raised in 55.5% (66/119). No patients demonstrated biochemical or clinical evidence of persistent primary or secondary hypogonadism, and none required pubertal induction or sex steroid replacement therapy. Primary hypothyroidism and subclinical hypothyroidism were identified in 1.7% (2/121) and 0.8% (1/121), respectively. Type 1 diabetes, type 2 diabetes, and impaired glucose tolerance were identified in 1.5% (2/135), 2.2% (3/135), and 1.5% (2/135), respectively. CONCLUSION: This is the largest analysis of endocrine characteristics in pediatric patients with BBS. Short stature and obesity are characteristic of pediatric BBS. However, hypogonadism, hypothyroidism, and insulin resistance are less prevalent compared with adult BBS populations. Longitudinal studies spanning pediatric and adult populations may further characterize the natural history of these endocrine conditions associated with BBS.
引用
- Varughese RS, Pujari D, Hatton E, et al. Endocrine characteristics in Bardet-Biedl syndrome from a large single-center pediatric multidisciplinary clinic. J Clin Endocrinol Metab. 2026. PMID: 42044156. doi:10.1210/clinem/dgag184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。